Clinical Trial Update: Study of Aranesp to Treat Anemia in Prostate Cancer Patients. [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating darbepoetin alfa (Aranesp) for treating anemia in prostate cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Prostate Cancer

Drugs mentioned

• ARANESP (DARBEPOETIN ALFA)

Snippet

Sponsor: University of Washington | Conditions: Prostate Cancer, Anemia | Phase 2 | Status: COMPLETED